Company search
Biotechnology & Healthcare: a sector on the mend?
What’s the prognosis for biotech and healthcare companies? How will the US election impact the sector, and could we see a recovery later this year?
Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Research
Related articles
Top performing investment trust ISAs over the last 25 years
18 trusts returned over £100,000 from a one-off £7,000 investment.
Who wants to be an ISA millionaire?
Ian Cowie dives into the investment trusts that would have made you over £1,000,000.
Related videos
Biotechnology & Healthcare: what are the challenges of investing in the sector?
Annabel Brodie-Smith asks managers about the challenges of investing in the Biotechnology & Healthcare sector.
Biotechnology & Healthcare: where are you finding opportunities?
A panel of Biotechnology & Healthcare managers discuss where they are currently finding opportunities.
Biotechnology & Healthcare: is the sector due a comeback?
Annabel Brodie-Smith, Brett Darke, Marek Poszepczynski and Geoff Hsu discuss whether Biotechnology & Healthcare is due a comeback.
Biotechnology & Healthcare: will the results of the US election make a difference for the sector?
Brett Darke, Marek Poszepczynski and Geoff Hsu on whether the results of the next US election will impact the Biotechnology & Healthcare sector.
Related Industry News
Hewitt: Scottish Mortgage on the front foot as my top growth trusts recover
Columbia Threadneedle investment company selector Peter Hewitt says the tide may finally be turning for Scottish Mortgage and other listed growth funds.
Hewitt: Scottish Mortgage on the front foot as top growth trusts recover
Columbia Threadneedle investment company selector Peter Hewitt says the tide may finally be turning for Scottish Mortgage and other listed growth funds.
David Stevenson: Biotech has turned from the bear
After a tough few years, increased fundraising suggests sentiment has improved and the current rally in biotech and life sciences could persist.
Numis: Trust sector shrank by £6.7bn in 2023
London-listed closed-end funds suffer a 'rare' year of outflows after share issues collapse in a bear market and investment companies return capital and buy back a record £4bn of stock.
Investment company news brought to you by Citywire Financial Publishers Limited
and QuotedData by Marten & Co.
Data provided by Morningstar.
Company documents provided by FE fundinfo.
